SUBSCRIBE
SUBSCRIBE
News   Business

Karo Bio AB: Year-End Report 2014

February 13, 2015 | 
1 min read

Regulatory News:

Karo Bio AB: (STO:KARO)

The full year 2014 and the fourth quarter in brief

•Net sales amounted to MSEK 30.1 (47.0), whereof the fourth quarter MSEK 8.1 (9.7)

Help employers find you! Check out all the jobs and post your resume.

Earnings Europe
MORE ON THIS TOPIC
cutting off a row of people into pieces
Layoffs
Editas Axes 60% of Staff, Sickle Cell Therapy After Failing to Find Partner
December 13, 2024
 · 
2 min read
 · 
Tristan Manalac
Novo Nordisk advertising flags and logo on facade
Regulatory
Novo Nordisk Snags Kidney Disease Expansion for Ozempic in Europe
December 12, 2024
 · 
1 min read
 · 
Kate Goodwin
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Bavarian, BenevolentAI, Chroma Medicine and Nvelop Therapeutics Cut Staff
December 12, 2024
 · 
205 min read
 · 
BioSpace Editorial Staff
Sign outside BioNTech's building in Germany
Breast cancer
BioNTech Builds Case for PD-L1/VEGF Bispecific With Promising Breast Cancer Data
December 11, 2024
 · 
2 min read
 · 
Tristan Manalac